The clinical use of drugs influencing neurotransmitters in the brain to promote motor recovery after stroke; a Cochrane systematic review

European Journal of Physical and Rehabilitation Medicine

Volumn 45, Issue 4, 2009, Pages 621-630

  Berends, H I ^a   Nijlant, J M M ^a,b   Movig, K L L ^c   Van Putten, M J A M ^c   Jannink, M J A ^a   Ijzerman, M J ^d  

^a ROESSINGH RESEARCH AND DEVELOPMENT   (Netherlands)

^b TWENTEBORG HOSPITAL   (Netherlands)

^c MEDISCH SPECTRUM TWENTE   (Netherlands)

^d UNIVERSITY OF TWENTE   (Netherlands)

Author keywords

Neurotransmitter agents; Recovery of functions; Stroke

Indexed keywords

AGENTS INTERACTING WITH TRANSMITTER, HORMONE OR DRUG RECEPTORS;

CONVALESCENCE; HUMAN; MOTOR ACTIVITY; PATHOPHYSIOLOGY; PHYSIOLOGY; PSYCHOLOGICAL ASPECT; REVIEW; STROKE;

HUMANS; MOTOR ACTIVITY; NEUROTRANSMITTER AGENTS; RECOVERY OF FUNCTION; STROKE;

EID: 77949362445     PISSN: 19739087     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (42)

1. Chen R, Cohen LG, Hallett M. Nervous system reorganization following injury. Neuroscience 2002;111:761-73.
2. Gu Q. Neuromodulatory transmitter systems in the cortex and their role in cortical plasticity. Neuroscience 2002;111:814-35.
3. Carmichael ST. Plasticity of cortical projections after stroke. Neuroscientist 2003;9:64-75.
4. Rossini PM, Dal Forno G. Integrated technology for evaluation of brain function and neuronal plasticity. Phys Med Rehabil Clin N Am 2004;25:263-306.
5. Bütefisch CM, Netz J, Weßling M, Seitz RJ, Hömberg V. Remote changes in cortical excitability after stroke. Brain 2003;126:470-81.
6. Bütefisch CM. Plasticity in the human cerebral cortex: lessons from the normal brain and from stroke. The Neuroscientist 2004;10:163-73.
7. Fazelli MS, Collingridge GL. In: Cortical plasticity LTP and LTD. BIOS Scientific Publishers Limited; 1996
8. Calautti C, Baron J. Functional neuroimaging studies of motor recovery after stroke in adults. A review. Stroke 2003;34:1553-66.
9. Martinsson L; Hȧrdemark H; Eksborg S. Amphetamines for improving recovery after stroke. Cochrane Database Syst Rev 2007; CD002090
10. Treig T, Werner C, Sachse M, Hesse S. No benefit from D-amphetamine when added to physiotherapy after stroke: a randomized, placebo-controlled study. Clin Rehabil 2003;17:590-9.
11. Platz T, Kim IH, Engel U, Pinkowski C, Eickhof C, Kutzner M. Amphetamine fails to facilitate motor performance and to enhance motor recovery among stroke patients with mild arm paresis: interim analysis and termination of a double blind, randomized, placebo-controlled trial. Restor Neurol Neurosci 2005;23:271-80.
12. Gladstone DJ, Danells CJ, Armesto A, McIlroy WE, Staines WR, Graham SJ et al. Physiotherapy coupled with dextroamphetamine for rehabilitation after hemiparetic stroke: a randomized, double-blind, placebo-controlled trial. Stroke 2006;37:179-85.
13. Rösser N, Floël A. Pharmacological enhancement of motor recovery in subacute and chronic stroke. Neurorehab 2008;23:95-103
14. Scheidtmann K, Fries W, Müller F, Koenig E. Effect of levodopa in combination with physiotherapy on functional motor recovery after stroke: a prospective, randomised, double-blind study. Lancet 2001;358:787-90.
15. Sonde L, Lökk J. Effects of amphetamine and/or L-dopa and physiotherapy after stroke - a blinded randomized study. Acta Neurol Scand 2007;115:55-9.
16. Grade C, Redford B, Chrostowski J, Toussaint L, Blackwell B. Methylphenidate in early poststroke recovery: a double-blind, placebo-controlled study. Arch Phys Med Rehabil 1998;79:1047-50.
17. Costa RM. Plastic corticostriatal circuits for action learning: what's dopamine got to do with it? Ann N Y Acad Sci 2007;1104:172-91.
18. Kandel ER, Schwartz JH, Jessell TM. In: Principles of neural science. 4th edition; New York: McGraw-Hill; 2000.
19. Miyai I, Reding MJ. Effects of antidepressants on functional recovery following stroke: a double-blind study. J Neuro Rehab 1998;12:5-13.
20. Dam M, Tonin P, De Boni A, Pizzolato G, Casson S, Ermani M et al. Effects of fluoxetine and maprotUine on functional recovery in poststroke hemiplegic patients undergoing rehabilitation therapy. Stroke 1996;27:1211-4.
21. Robinson RG, Schultz SK, Castillo C, Kopel T, Rosier JT, Newman M et al. Nortriptyline versus fluoxetine in the treatment of depression and in short-term recovery after stroke: a placeb-controlled, double-blind study. Am J Psychiatry 2000;157:351-9.
22. Kraus RL, Li Y, Jovanovska A, Renger JJ. Trazodone inhibits T-type calcium channels. Neuropharmacology 2007;53:308-17.
23. Jacobs BL, Fornal CA. Serotonin and motor activity. Curr Opin Neurobiol 1997;7:820-5.
24. Van Tulder MW, Assendelft WJJ, Koes BW, Bouter LM. Method Guidelines for systematic reviews in the Cochrane Collaboration back review group for spinal disorders. Spine 1997;22:2323-30.
25. Pariente J, Loubinoux I, Carel C, Albucher J, Leger A, Manelfe C et al. Fluoxetine modulates motor performance and cerebral activation of patients recovering from stroke. Ann Neurol 2001;50: 718-29.
26. Zittel S, Weiller C, Liepert J. Citalopram improves dexterity in chronic stroke patients. Neurorehabil Neural Repair 2008;22: 311-4.
27. Zittel S, Weiller C, Liepert J. Reboxetine improves motor function in chronic stroke. A pilot study. J Neurol 2007; 254:197-201.
28. Hasbroucq T, Rihet P, Blin O, Possamai CA. Serotonin and human information processing: fluvoxamine can improve reaction time performance. Neurosci Lett 1997;229:204-8.
29. Rihet P, Hasbroucq T, Blin O, Possamai CA. Serotonin and human information processing: an electromyographic study of the effects of fluvoxamine on choice reaction time. Neurosci Lett 1999;265: 143-6.
30. Restemeyer C, Weiller C, Liepert J. No effect of a levodopa single dose on motor performance and motor excitability in chronic stroke patients. A double-blind placebo-controlled cross-over pilot study. Restor Neurol Neurosci 2007;25:143-50.
31. Van Genderen HI, Nijlant JM, van Putten MJ, Movig KL, IJzerman MJ. Single dose of fluoxetine increases muscle activation in chronic stroke patients. Clin Neuropharmacol 2009;32:1-5.
32. Loubinoux I, Boulanouar K, Ranjeva J, Carel C, Berry I, Rascol O et al. Cerebral functional magnetic resonance imaging activation modulated by a single dose of the monoamine neurotransmission enhancers fluoxetine and fenozolone during hand sensori-motor tasks. J Cereb Blood Flow Metab 1999;19:1365-75.
33. Loubinoux I, Pariente J, Boulanouar K, Carel C, Manelfe C, Rascol O et al. A single dose of the serotonin neurotransmisstion agonist paroxetine enhances motor output: double-blind, placebo-controlled, fMRI study in healthy subjects. NeuroImage 2002;15:26-36.
34. Ilic TV, Korchounov A, Ziemann U. Complex modulation of human motor cortex excitability by the specific serotonin re-uptake inhibitor sertraline. Neurosci Lett 2002;319:116-20.
35. Pleger B, Schwenkreis P, Grünberg C, Malin JP, Tegenthoff M. Fluoxetine facilitates use-dependent excitability of human primary motor cortex. Clin Neurophysiol 2004;115:2157-63.
36. Gerdelat-Mas A, Loubinoux I, Tombare D, Rascol O, Chollet F, Simonetta-Moreau M. Chronic administration of selective serotonin reuptake inhibitor (SSRI) paroxetine modulates human motor cortex excitability in healthy subjects. NeuroImage 2005;27:314-22.
37. Loubinoux I, Tombari D, Pariente J, Gerdelat-Mas A, Franceries X, Cassol E et al. Modulation of behavior and cortical motor activity in healthy subjects by a chronic administration of a serotonin enhancer. NeuroImage 2005;27:299-313.
38. Chemerinski E, Robinson RG, Kosier JT. Improved recovery in activities of daily living associated with remission of poststroke depression. Stroke 2001;32:113-7.
39. Gainotti G, Antonucci G, Marra C, Paolucci S. Relation between depression after stroke, antidepressant therapy, and functional recovery. J Neurol Neurosurg Psychiatry 2001;71:258-61.
40. Bilge C, Koçer E, Koçer A, Türk Börü Ü. Depression and functional outcome after stroke: the effect of antidepressant therapy on functional recovery. Eur J Phys Rehabil Med 2008;44:13-8.
41. Saxena SK, Ng TP, Koh G, Yong D, Fong NP. Is improvement in impaired cognition and depressive symptoms in post-stroke patients associated with recovery in activities of daily living? Acta Neurol Scand 2007;115:339-46.
42. Hackett ML, Anderson CS, House AO. Management of depression after stroke: a systematic review of pharmacological therapies. Stroke 2005;36:1098-103.